Department of Translational Medical Science, Section of Pediatrics, University of Naples "Federico II", Via S. Pansini, 5, 80131, Naples, Italy.
Santobono-Pausilipon Children's Hospital, Naples, Italy.
Ital J Pediatr. 2021 Apr 21;47(1):98. doi: 10.1186/s13052-021-01047-y.
Despite ibuprofen widely recognized safety profile, an increase of suspected adverse events has been reported in the last decade in parallel with its growing over-the-counter use. The aims of this study were to assess the therapeutic approach to the feverish child and to evaluate the main indications and the most frequent adverse events related to ibuprofen administration in children.
A specific questionnaire-form regarding the management of ibuprofen therapy in children was distributed among a sample of pediatricians all over the Italian territory between September and October 2020. An electronic data collection through a specifically designed web-based platform was performed among the participating pediatricians.
One-hundred-eighty-one pediatricians completed the survey. In case of fever, 177 (98%) participants prescribe paracetamol, while only 4 (2%) preferred ibuprofen as first choice. One-hundred-twenty-eight pediatricians (71%) administer paracetamol alone, while 53 (29.2%) use the combined/alternating treatment with ibuprofen. Ibuprofen is mostly administered for musculoskeletal pain (30%), upper respiratory tract infection (20%), headache (15%) and post-surgical pain (9%). Sixty-three (35%) out of 181 participating pediatricians reported 191 adverse events during ibuprofen administration. The most common were gastrointestinal (GI), with GI bleeding being reported in 30/191 cases (15.7%), epigastric pain in 29/191 (15.1%), non-specified abdominal pain in 22/191 (11.1%) and nausea/vomiting in 21/191 (11%). Severe adverse events including kidney damage (3.1%), complicated infections (0.5%), pneumonia associated empyema (0.5%), soft tissue infection (0.5%) and disseminated intravascular coagulation (0.5%) were also reported. The adverse events led to a hospitalization in 12% of children. In 53/191 cases (28%) the adverse events were related to a wrong dosage or prolonged therapy or errors in frequency of administration.
This survey demonstrate a sufficient awareness of Italian pediatricians regarding ibuprofen-prescribing patterns with the only possible concern related to the relatively high percentage of pediatricians performing a combining/alternating use of paracetamol and ibuprofen. The reported adverse events were mild in most of the cases and often related to errors in dosage, frequency and treatment duration, emphasizing the need for a major caution of both practitioners and patients in their use.
尽管布洛芬被广泛认为安全性良好,但在过去十年中,随着其在非处方药物中的使用日益增多,疑似不良反应的报告也有所增加。本研究旨在评估发热患儿的治疗方法,并评估儿童使用布洛芬的主要适应证和最常见的不良反应。
2020 年 9 月至 10 月期间,我们向意大利各地的儿科医生分发了一份关于儿童布洛芬治疗管理的专门问卷。通过专门设计的网络平台,对参与的儿科医生进行电子数据收集。
181 名儿科医生完成了调查。在发热的情况下,177 名(98%)参与者首选扑热息痛,而只有 4 名(2%)首选布洛芬。128 名(71%)儿科医生单独使用扑热息痛,53 名(29.2%)使用布洛芬联合/交替治疗。布洛芬主要用于治疗肌肉骨骼疼痛(30%)、上呼吸道感染(20%)、头痛(15%)和术后疼痛(9%)。在 181 名参与的儿科医生中,有 63 名(35%)报告了 191 例布洛芬治疗期间的不良反应。最常见的是胃肠道(GI)不良反应,其中 30/191 例(15.7%)报告 GI 出血,29/191 例(15.1%)报告上腹痛,22/191 例(11.1%)报告非特异性腹痛,21/191 例(11.1%)报告恶心/呕吐。还报告了一些严重的不良反应,包括肾损伤(3.1%)、复杂感染(0.5%)、肺炎相关脓胸(0.5%)、软组织感染(0.5%)和弥散性血管内凝血(0.5%)。这些不良反应导致 12%的患儿住院治疗。在 191 例不良反应中,53 例(28%)与剂量错误、延长治疗时间或给药频率错误有关。
本调查表明,意大利儿科医生对布洛芬处方模式有足够的认识,唯一可能令人关注的是,相当一部分儿科医生同时使用扑热息痛和布洛芬进行联合/交替治疗。报告的不良反应大多为轻度,且常与剂量、频率和治疗持续时间有关,这强调了从业者和患者在使用时都需要高度谨慎。